tradingkey.logo

Teladoc Health Inc

TDOC

7.890USD

+0.990+14.35%
Fechamento 06/23, 16:00ETCotações atrasadas em 15 min
1.38BValor de mercado
PerdaP/L TTM

Teladoc Health Inc

7.890

+0.990+14.35%
Mais detalhes de Teladoc Health Inc Empresa
Teladoc Health, Inc. provides virtual healthcare services. The Company operates through two segments: Teladoc Health Integrated Care (Integrated Care) and BetterHelp. The Integrated Care segment includes a suite of global virtual medical services including general medical, medical services, specialty medical, chronic condition management, mental health, and enabling technologies and enterprise telehealth solutions for hospitals and health systems. Services in this segment are distributed primarily on a business-to-business (B2B) basis. The BetterHelp segment primarily consists of its direct-to-consumer (D2C) mental health platform. The online counseling and therapy services are provided via its network of over 35,000 licensed clinicians, leveraging its platform for Web, mobile app, phone, and text-based interactions. Its Teladoc Health family of brands, including Teladoc and BetterHelp, deliver access to advice and resolution for an array of healthcare needs.
Informações da empresa
Código da empresaTDOC
Nome da EmpresaTeladoc Health Inc
Data de listagemJul 01, 2015
Fundado em2008
CEOMr. Charles (Chuck) Divita, III
Número de funcionários5500
Tipo de títulosOrdinary Share
Fim do ano fiscalJul 01
Endereço155 E 44Th Street
CidadeNEW YORK
Bolsa de valoresNYSE Consolidated
PaísUnited States of America
Código postal10017
Telefone12036352002
Sitehttps://www.teladochealth.com/
Código da empresaTDOC
Data de listagemJul 01, 2015
Fundado em2008
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Charles (Chuck) Divita, III
Mr. Charles (Chuck) Divita, III
Chief Executive Officer, Director
Chief Executive Officer, Director
156.64K
--
Ms. Mala Murthy
Ms. Mala Murthy
Chief Financial Officer
Chief Financial Officer
132.44K
-9.47%
Mr. Adam C. Vandervoort, J.D.
Mr. Adam C. Vandervoort, J.D.
Chief Legal Officer, Secretary
Chief Legal Officer, Secretary
69.77K
-7.68%
Ms. Kelly Bliss
Ms. Kelly Bliss
President, U.S. Group Health
President, U.S. Group Health
50.27K
-8.47%
Ms. Sandra L. Fenwick
Ms. Sandra L. Fenwick
Independent Director
Independent Director
40.43K
--
Mr. David L. Shedlarz
Mr. David L. Shedlarz
Independent Director
Independent Director
32.28K
+117.92%
Dr. Mark Douglas Smith, M.D.
Dr. Mark Douglas Smith, M.D.
Independent Director
Independent Director
8.36K
--
Mr. David B. Snow, Jr.
Mr. David B. Snow, Jr.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. J. Eric Evans
Mr. J. Eric Evans
Independent Director
Independent Director
--
--
Mr. Thomas G. Mckinley
Mr. Thomas G. Mckinley
Independent Director
Independent Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Charles (Chuck) Divita, III
Mr. Charles (Chuck) Divita, III
Chief Executive Officer, Director
Chief Executive Officer, Director
156.64K
--
Ms. Mala Murthy
Ms. Mala Murthy
Chief Financial Officer
Chief Financial Officer
132.44K
-9.47%
Mr. Adam C. Vandervoort, J.D.
Mr. Adam C. Vandervoort, J.D.
Chief Legal Officer, Secretary
Chief Legal Officer, Secretary
69.77K
-7.68%
Ms. Kelly Bliss
Ms. Kelly Bliss
President, U.S. Group Health
President, U.S. Group Health
50.27K
-8.47%
Ms. Sandra L. Fenwick
Ms. Sandra L. Fenwick
Independent Director
Independent Director
40.43K
--
Mr. David L. Shedlarz
Mr. David L. Shedlarz
Independent Director
Independent Director
32.28K
+117.92%
Detalhamento da receita
Moeda: USDAtualizado em: dom, 6 de abr
Moeda: USDAtualizado em: dom, 6 de abr
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q3
FY2022Q2
Por EmpresaUSD
Nome
Receita
Proporção
Access Fees Revenue
2.22B
86.21%
Other
354.35M
13.79%
Por RegiãoUSD
Nome
Receita
Proporção
United States
2.16B
84.06%
International
409.62M
15.94%
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Access Fees Revenue
2.22B
86.21%
Other
354.35M
13.79%
Distribuição de ações
Atualizado em: sex, 16 de mai
Atualizado em: sex, 16 de mai
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
The Vanguard Group, Inc.
11.19%
BlackRock Institutional Trust Company, N.A.
7.28%
Renaissance Technologies LLC
3.73%
Point72 Asset Management, L.P.
3.71%
Two Sigma Investments, LP
3.02%
Other
71.06%
Investidores
Investidores
Proporção
The Vanguard Group, Inc.
11.19%
BlackRock Institutional Trust Company, N.A.
7.28%
Renaissance Technologies LLC
3.73%
Point72 Asset Management, L.P.
3.71%
Two Sigma Investments, LP
3.02%
Other
71.06%
Tipos de investidores
Investidores
Proporção
Investment Advisor/Hedge Fund
32.79%
Hedge Fund
17.95%
Investment Advisor
17.80%
Research Firm
4.68%
Individual Investor
1.09%
Bank and Trust
0.64%
Pension Fund
0.48%
Sovereign Wealth Fund
0.10%
Venture Capital
0.04%
Other
24.43%
Participação acionária institucional
Atualizado em: ter, 4 de mar
Atualizado em: ter, 4 de mar
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q1
1023
133.05M
75.84%
-33.56M
2024Q4
1063
134.61M
77.51%
-37.55M
2024Q3
1133
134.94M
78.45%
-32.89M
2024Q2
1195
142.47M
83.22%
-14.73M
2024Q1
1317
130.90M
77.27%
-19.41M
2023Q4
1432
129.36M
77.56%
-18.52M
2023Q3
1538
125.63M
75.92%
-38.92M
2023Q2
1640
129.13M
78.35%
-41.97M
2023Q1
1761
137.47M
83.88%
-27.34M
2022Q4
1860
135.36M
83.16%
-23.04M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
The Vanguard Group, Inc.
18.43M
10.61%
+1.03M
+5.92%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
13.67M
7.87%
-227.05K
-1.63%
Dec 31, 2024
Renaissance Technologies LLC
5.67M
3.27%
+763.26K
+15.54%
Dec 31, 2024
Point72 Asset Management, L.P.
11.18M
6.44%
+2.81M
+33.63%
Dec 31, 2024
Two Sigma Investments, LP
4.28M
2.46%
+3.56M
+492.73%
Dec 31, 2024
Dimensional Fund Advisors, L.P.
3.53M
2.03%
+8.89K
+0.25%
Dec 31, 2024
State Street Global Advisors (US)
5.08M
2.92%
+446.18K
+9.63%
Dec 31, 2024
Geode Capital Management, L.L.C.
3.95M
2.27%
+22.66K
+0.58%
Dec 31, 2024
Maple Rock Capital Partners, Inc.
3.56M
2.05%
+2.33M
+189.51%
Dec 31, 2024
Wellington Management Company, LLP
3.14M
1.81%
-60.80K
-1.90%
Dec 31, 2024
Ver Mais
ETFs Relacionados
Atualizado em: sex, 6 de jun
Atualizado em: sex, 6 de jun
Nome
Proporção
Counterpoint Quantitative Equity ETF
1.88%
Global X HealthTech ETF
1.35%
Fidelity Digital Health ETF
1.12%
First Trust Indxx Metaverse ETF
0.98%
First Trust Nasdaq Lux Digi Health Solutions ETF
0.59%
Principal U.S. Small-Cap ETF
0.45%
Langar Global HealthTech ETF
0.45%
SPDR S&P Kensho New Economies Composite ETF
0.24%
iShares U.S. Healthcare Providers ETF
0.21%
Avantis US Small Cap Equity ETF
0.14%
Ver Mais
Counterpoint Quantitative Equity ETF
Proporção1.88%
Global X HealthTech ETF
Proporção1.35%
Fidelity Digital Health ETF
Proporção1.12%
First Trust Indxx Metaverse ETF
Proporção0.98%
First Trust Nasdaq Lux Digi Health Solutions ETF
Proporção0.59%
Principal U.S. Small-Cap ETF
Proporção0.45%
Langar Global HealthTech ETF
Proporção0.45%
SPDR S&P Kensho New Economies Composite ETF
Proporção0.24%
iShares U.S. Healthcare Providers ETF
Proporção0.21%
Avantis US Small Cap Equity ETF
Proporção0.14%
Dividendo
Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
KeyAI